bioAffinity Technologies, Inc.
BIAF
$0.4698
-$0.0292-5.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.89% | -16.68% | 11.46% | -1.84% | 2.66% |
| Total Depreciation and Amortization | 142.53% | 455.27% | 886.58% | 1,125.97% | 2,372.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.17% | 79.66% | -71.67% | -62.91% | -60.66% |
| Change in Net Operating Assets | -80.05% | -145.03% | 143.80% | 218.65% | 688.88% |
| Cash from Operations | -20.32% | -25.90% | -18.11% | -38.04% | -48.32% |
| Capital Expenditure | -243.91% | 74.38% | 77.95% | 87.28% | 89.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 96.42% | 97.31% | -775.49% | -779.35% | -904.32% |
| Total Debt Issued | -- | -- | -96.37% | -96.56% | -- |
| Total Debt Repaid | -4.67% | 56.91% | 60.88% | 54.98% | 50.36% |
| Issuance of Common Stock | -- | -- | -81.36% | -81.36% | -- |
| Repurchase of Common Stock | -- | -247,350.00% | -247,350.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -519.49% | -- |
| Cash from Financing | 1,731.22% | 526.92% | -87.44% | -87.41% | -102.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.02% | 58.25% | -192.72% | -183.70% | -185.47% |